As artificial intelligence becomes more embedded in clinical development, the focus is shifting from capability to trust. At ...

Samsung Biologics and Fujifilm Biotechnologies discuss how regional manufacturing, dual sourcing and networked CDMO capacity ...

What it takes to produce complex OSD drug products from the earliest stages of development to rapid, low-risk tech transfer ...

Henny Zijlstra, Chief Commercial Officer of Ardena, discusses the integrated CDMO model, Ardena’s new laboratory in New ...

Incyte completed its previously announced acquisition of Vega Therapeutics, a wholly owned subsidiary of Star Therapeutics.